Kyverna Therapeutics, Inc. (KYTX)
5.15
-0.01
(-0.19%)
USD |
NASDAQ |
Nov 04, 16:00
5.12
-0.03
(-0.58%)
After-Hours: 19:37
Kyverna Therapeutics Price : 5.15 for Nov. 4, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 03, 2026 | 5.28 | 5.48 | 5.12 | 5.16 | 704672.0 |
| Nov 02, 2026 | 5.70 | 5.84 | 5.092 | 5.22 | 822310.0 |
| Oct 30, 2026 | 5.74 | 5.87 | 5.55 | 5.67 | 640171.0 |
| Oct 29, 2026 | 5.91 | 6.12 | 5.83 | 5.85 | 854640.0 |
| Oct 28, 2026 | 5.58 | 5.935 | 5.56 | 5.89 | 995409.0 |
| Oct 27, 2026 | 5.24 | 5.67 | 5.16 | 5.63 | 916659.0 |
| Oct 26, 2026 | 5.35 | 5.41 | 5.18 | 5.27 | 810112.0 |
| Oct 23, 2026 | 5.68 | 5.68 | 5.36 | 5.39 | 827751.0 |
| Oct 22, 2026 | 5.825 | 5.985 | 5.67 | 5.73 | 519387.0 |
| Oct 21, 2026 | 6.15 | 6.30 | 5.80 | 5.84 | 829516.0 |
| Oct 20, 2026 | 5.83 | 6.20 | 5.80 | 6.04 | 766309.0 |
| Oct 19, 2026 | 5.71 | 5.94 | 5.67 | 5.83 | 837714.0 |
| Oct 16, 2026 | 5.94 | 6.05 | 5.64 | 5.67 | 726279.0 |
| Oct 15, 2026 | 5.67 | 6.02 | 5.67 | 5.97 | 779435.0 |
| Oct 14, 2026 | 5.76 | 5.845 | 5.61 | 5.685 | 1.276M |
| Oct 13, 2026 | 6.17 | 6.17 | 5.755 | 5.77 | 1.241M |
| Oct 12, 2026 | 6.34 | 6.46 | 6.19 | 6.21 | 417111.0 |
| Oct 09, 2026 | 6.20 | 6.58 | 6.175 | 6.39 | 876449.0 |
| Oct 08, 2026 | 6.06 | 6.216 | 5.960 | 6.18 | 1.317M |
| Oct 07, 2026 | 6.12 | 6.31 | 6.02 | 6.17 | 650547.0 |
| Oct 06, 2026 | 6.38 | 6.45 | 6.13 | 6.16 | 739522.0 |
| Oct 05, 2026 | 6.30 | 6.435 | 6.00 | 6.32 | 813484.0 |
| Oct 02, 2026 | 6.62 | 6.754 | 6.17 | 6.22 | 1.183M |
| Oct 01, 2026 | 6.80 | 6.91 | 6.51 | 6.52 | 788497.0 |
| Sep 30, 2026 | 6.875 | 7.10 | 6.73 | 6.80 | 746992.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 61.67 |
| Oncolytics Biotech, Inc. | 0.4256 |
| Sangamo Therapeutics, Inc. | 0.117 |
| Sarepta Therapeutics, Inc. | 19.00 |
| Anixa Biosciences, Inc. | 3.27 |
Price Related Metrics
| Price to Book Value | 1.915 |
| Earnings Yield | -57.00% |
| Market Cap | 317.09M |